Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
0.93
-0.04 (-4.12%)
At close: Aug 18, 2025, 3:59 PM
0.91
-1.98%
After-hours: Aug 18, 2025, 07:41 PM EDT

Ovid Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-38.18M -24.97M -26.43M -32.5M -29.75M -50.68M -52.34M -48.52M -49.24M -51.42M -54.17M -68.66M -68.08M -69.28M 122.83M 126.81M 121.76M 115M
Depreciation & Amortization
569K 618K 613K 854.39K 1.09M 1.33M 1.6M 1.64M 1.65M 1.71M 1.38M 998.61K 635.42K 236.15K 237.08K 263.17K 289.91K 314.7K
Stock-Based Compensation
5.07M 5.59M 6.28M 6.8M 7.13M 7.34M 7.29M 7.23M 7.38M 7.15M 6.56M 6.14M 5.52M 5.06M 5.05M 5.79M 7.24M 7.54M
Other Working Capital
-4.38M 1.93M 362K 2.86M 5.17M -848.9K 635.1K -1.52M -2.88M -3.76M -3.06M -727.9K -4.88M -3.73M -18.52M -20.56M -3.63M 2.26M
Other Non-Cash Items
-1.68M -29.25M -34.44M -35.44M -36.62M -9.02M -4.46M -1.91M -1.24M -501.8K -764.94K 6.31M 5.88M 7.85M 20.98M 21.63B 21.63B 21.63B
Deferred Income Tax
n/a n/a n/a -105.41K 240.94K -247.15K -247.15K -141.74K -488.09K n/a n/a -0.00 -0.00 -0.00 -0.00 -21.62B -21.62B -21.62B
Change in Working Capital
-5.85M -1.54M -1.98M 2.53M 5.01M 915.54K 2.39M -1.33M -3.73M -4.19M -8.23M -2.84M -1.17M -4.62M -16.81M -16.76M -3.79M 4.94M
Operating Cash Flow
-40.07M -49.55M -55.96M -57.86M -52.9M -50.35M -45.78M -43.04M -45.67M -47.25M -55.23M -58.05M -56.25M -62.37M 118.61M 116.1M 125.5M 127.73M
Capital Expenditures
-18K -52K -71K -50.22K -59.46K -142.9K -137.9K -199.68K -213.03K -1.36M -1.42M -1.52M -1.52M -254.06K -189.41K -117.93K -143.3K -199.21K
Cash Acquisitions
n/a n/a n/a 48.5M 52.86M 52.97M 52.97M 6.96M 109.64K n/a n/a -2.45M n/a n/a n/a 9.95B 9.95B 9.95B
Purchase of Investments
-36.27M -68.35M -73.25M -115.05M -134.69M -112.48M -112.44M -118.04M -118.12M -182.72M -172.96M -110.49M -81.1M -3.26M -3.26M -9.95B -9.95B -9.95B
Sales Maturities Of Investments
75M 108M 128M 100M 115M 110M 120M 170M 175M 130M 90M 31.59M 1.59M 1.59M 1.59M -45M -45M -14M
Other Investing Acitivies
27K -89K -89K -48.62M -52.97M -62.97M -62.97M -16.96M -14.55M -84.08M -85.08M -82.58M -80.68M -2.63M -1.63M 43.37M 43.4M 44.98M
Investing Cash Flow
38.74M 39.51M 54.59M -15.21M -19.87M -12.62M -2.58M 41.77M 44.17M -56.58M -87.88M -83.88M -81.98M -2.89M -1.82M -1.75M -1.72M 30.8M
Debt Repayment
n/a n/a n/a 30M 30M 30M 30M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -43.6K -43.6K -43.6K -43.6K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a n/a n/a 67K 23.4K 105.03K 214.58K 180.66K 333.44K 800.86K 807.5K 904.08K 783.49K 402.04K 455.16K
Financial Cash Flow
51K 407K 622K 30.66M 30.84M 30.7M 30.54M 458.22K 316.13K 214.58K 180.66K 333.44K 800.86K 807.5K 904.08K 562.42K 47.13M 47.19M
Net Cash Flow
-1.28M -9.64M -740.52K -42.42M -41.93M -32.28M -17.83M -820.66K -1.19M -103.62M -142.93M -141.59M -137.42M -64.45M 117.69M 114.91M 170.91M 205.71M
Free Cash Flow
-40.06M -49.58M -56M -57.91M -52.96M -50.5M -45.92M -43.24M -45.88M -48.61M -56.65M -59.57M -57.76M -62.63M 118.42M 115.98M 125.36M 127.53M